Make your own free website on
HomeCyberwareBiowareEugenicsNews and UpdatesFazed Consulting
Log InFile Download SectionLinksShadowTalkCorporationsNew MagicNew TechnologyPlacesMatrix News Network
Matrox News Network

Endocrine Enhancements Foils Hostile Takeover Bid

AP - January 3, 2053: Endocrine Enhancements President and CEO, David Geller, announced today that EE has foiled an attempt at a hostile takeover. Mr. Geller, who founded EE back in 2051, when it was still called LifeSavers, made his announcemnt in a press release sent to all major sources. According to the release, EE was the subject of a hostile takeover attempt by Universal Omnitech. As many people already know, EE and Universal have been working closely together for the past year in the biotechnology field.

"Although mutually profitable, our relationship was never sanguine" says Mr. Geller. "Right from the beginning, Universal insisted on total access to all our files, both technical and financial. We tried to resist, but found them intruding at every level. Finally, we were forced to sever our relationship. The boys at Universal were, shall we say, less than pleased."

In February of this year, Universal Omnitech launched a hostile takeover attempt of Endocrine Enhancments, using subsidiary overseas corporations. Somehow, this move was blocked by officials at EE; a bold financial maneuver that has industry experts scratching their heads in perplexity.

George Nafer, well known Market Analyst, and writer for the Wall Street Journal, admits his confusion. "There is no way a relatively small company like EE should have been able to resist the takeover attempt," says Mr. Nafer. "They lack the capital to buy up stock. It is also well known that both Morris Reddman and Monica Carsters have been threatening to sell their shares for quite some time. On paper, it should have been the perfect takeover."

Officials at Universal Omnitech declined to be interviewed. In a prepared statement, they say "Our relationship with Endocrine Enhancements, i.e. takeover bid, was attempted solely to recoup losses in our previous research-orientated relationship. It was our decision that EE management was less than competant, and if the company was to survive, needed new, effective leadership. Upon further examination of EE's accounts, it was decided that EE was not fiscally viable, and our takeover bid was ended, voluntarily on our part."